PRODUCTS
PRODUCTS
APIs and intermediates
PRODUCTS
Linagliptin intermediates
PRODUCTS
Crisaborole API & Intermedia… Topiroxostat API & Intermedi… Tavaborole API & Intermedia… Upadacitinib API & Intermed… BrexpiprazoleAPI & Intermedi… TEST Others Ticagrelor Intermediates Others Parecoxib sodium Intermediat… Canagliflozin Intermediates Empagliflozin Intermediates Dapagliflozin Intermediates Tofacitinib Intermediates Baricitinib Intermediates Baricitinib Intermediates Vonoprazan Fumarate Intermed… Febuxostat Intermediates Ceftaroline fosamil Interme… Rivaroxaban Intermediates Avatrombopag Intermediates Ramelteon Intermediates Pimavanserin Intermediates Intermediates of Carbapenems… Dabigatran etexilate Interme… Crisaborole Intermediates Finafloxacin Hydrochloride I… Meropenem Sacubitril Apixaban Intermediates Zolpidem tartrater Intermedi… Tolvaptan Intermediates Edoxaban Intermediates Nucleus and intermediates of… Acotiamide intermediates Apremilast intermediates Roxadustat intermediates Linagliptin intermediates Ibrutinib Intermediates Eltrombopag Intermediates Posaconazole Intermediates | Name | Linagliptin |
| Purity | ≥99% |
| Appearance | - |
| Synonym | Tradjenta |
| Cas No | 668270-12-0 |
| Molecular Formula | C25H28N8O2 |
| Molecular Weight | 472.54 |
| Structural Formula |  |
| Product Introduction | Linagliptin[668270-12-0] is used to improve the control of blood sugar level in type 2 diabetic patients by combining diet and exercise. |
| Product Status | Linagliptin[668270-12-0].Our company hascommercialized this product for long-term stable supply |
| ?Product Quality | For futher detailed of Linagliptin,please download the certification of analysis of 668270-12-0. |
| ??Contact Information | If you are interested in Linagliptin[668270-12-0],we will provide you with reasonable |
Copyright Bayeebio Biotech (Shanghai) Co., Ltd. Shanghai 滬ICP備16015574號
